0001104659-24-001954.txt : 20240105 0001104659-24-001954.hdr.sgml : 20240105 20240105210349 ACCESSION NUMBER: 0001104659-24-001954 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240103 FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMES STEPHEN M CENTRAL INDEX KEY: 0000905479 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 24518108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 tm242134-5_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-01-03 0 0001175680 CytoDyn Inc. CYDY 0000905479 SIMES STEPHEN M 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 1 0 0 0 0 Non-qualified stock option (right to buy) 0.21 2024-01-03 4 A 0 800000 0 A 2034-01-03 Common Stock 800000 800000 D 466,662 shares vested on January 3, 2024; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from January 2024 through May 2024. /s/ Antonio Migliarese, Attorney-in-Fact for Stephen M Simes 2024-01-05